Inceptor Bio to Present IB-T101 Data at the 2025 SITC Annual Meeting
Morrisville, NC — Inceptor Bio, a clinical-stage biotechnology company pioneering next-generation cell therapies to cure cancer, announced today that it will present on IB-T101, its lead CAR-T program targeting CD70, at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting. IB-T101 is an autologous, OUTLAST™-conditioned CAR-T therapy developed for patients with advanced clear cell […]
Inceptor Bio to Present IB-T101 and OUTLAST™ Platform at ASCO 2025
Morrisville, NC – Inceptor Bio, a clinical-stage biotechnology company pioneering next-generation cell therapies to cure cancer, announced today that it will present an update on IB-T101, its lead CAR-T program targeting CD70, at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. IB-T101 is an autologous CAR-T therapy developed for patients with advanced clear […]
Inceptor Bio to Present at AACR 2025: Spotlight on IB-T101 and the OUTLAST™ Platform
Morrisville, NC – Inceptor Bio, a clinical-stage biotechnology company pioneering next-generation cell therapies to cure cancer, today announced that it will present clinical progress on its lead program, IB-T101, at the American Association for Cancer Research (AACR) Annual Meeting 2025. IB-T101 is an autologous CAR-T therapy targeting CD70, developed for patients with advanced clear cell […]
Inceptor Bio Announces First Patient Dosed in Clinical Trial of IB-T101 for Clear Cell Renal Cell Carcinoma (ccRCC) and $21M Series A2 Financing
Research Triangle Park, NC – Inceptor Bio, a clinical-stage biotechnology company pioneering next-generation cell therapies, today announced that the first patient has been dosed in the clinical trial of IB-T101, the company’s lead program. The trial marks a significant milestone for Inceptor Bio’s efforts to address the unmet medical needs of patients with clear cell […]
Inceptor Bio to Present at Biotech Showcase
Morrisville, NC – Inceptor Bio, a clinical-stage biotech company pioneering next-generation cell therapies to cure cancer, today announced a presentation at the Biotech Showcase in San Francisco. Biotech Showcase Presentation Details: Presenter: Matthias Schroff, Ph.D. (CEO, Inceptor Bio) Date: Wednesday, January 15, 2025 Time: 10:00 AM PT Location: Franciscan D (Ballroom Level) Inceptor […]
Inceptor Bio and GRIT Bio Announce Strategic Partnership to Advance IB-T101, a Next-Generation Solid Tumor CAR-T Utilizing the OUTLAST™ Platform
Inceptor Bio, a leading innovator in cell therapy, and GRIT Bio, a clinical-stage immunotherapy developer, today announced a strategic partnership to advance IB-T101, a potentially best-in-class CAR-T therapy targeting solid tumors. IB-T101, Inceptor Bio’s autologous CD70 CAR-T program, utilizes the proprietary OUTLAST™ platform to reprogram T cells for superior stemness, durability, and effector function in […]
Inceptor Bio to Present at ASGCT in Baltimore
Morrisville, NC – Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced two poster presentations at the ASGCT in Baltimore (AACR ANNUAL MEETING 2024) Poster Presentation #819: Presenter: Warren Anderson, Ph.D. Title: OUTLASTTM CAR-T Cells Exhibit Superior Effector Function Against Solid Tumors Date: May 8th, 2024 Time: 5:30pm EST Poster Presentation […]
Inceptor Bio to Present at AACR in San Diego
Morrisville, NC – Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced the poster presentation at AACR in San Diego (AACR Annual Meeting 2024 in San Diego) Presenter: Kilsoo Jeon, Ph.D. Title: Novel costimulatory domain improves CAR-Monocyte activity against tumors Date: April 9th, 2024 Time: 1:30PM and 5:00PM PT About Inceptor […]
Inceptor Bio to Present at the BioCentury Inc. East-West Summit in Boston
Morrisville, NC – Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced the presentation at the BioCentury-BayHelix East-West Summit 2023 Date: October 4, 2023 Time: 9:00 am EST About Inceptor Bio Founded in 2020, Inceptor Bio is a biotechnology company strategically advancing a pipeline of diversified cell therapies in oncology. Inceptor […]
Inceptor Bio to Present at CAR-TCR Summit in Boston
Morrisville, NC – Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced the presentation at the CAR-TCR Summit in Boston (8th CAR-TCR Summit | Boston, MA (car-tcr-summit.com) Presenter: Sumiti Jain, PhD, VP of R&D Title: Overcoming Resistance & the Tumor Microenvironment with CAR-Macrophage Therapies Date: August 29th Time: 11am EST About […]
